RELAXaHEAD for Headache Patients (Phase I)

CompletedNot a drug-phase studyMS (type not specified)NCT03183791

What it found

Paper found, not read

A paper reports the results; we have not read it yet. See Papers below.

What was tested

Treatment tested

  • RELAXaHEAD app

Compared with

  • Monitored Usual Care (MUC)

What it measured

Main measures

  • Number of days spent logging headache data as determined by entries into the RELAXaHEAD app

    90 Days

    Feasibility
  • Number of days spent doing PMR as determined with the backend analytics in the RELAXaHEAD app backend analytics in the RELAXaHEAD app

    90 Days

    Feasibility
  • Minutes/day spent doing PMR as determined with the backend analytics in the RELAXaHEAD app

    90 Days

    Feasibility
  • Satisfaction using Likert scale questions on RELAXaHEAD usability, content, and functionality

    Baseline

    Quality of life (reported by participants)Feasibility

Who could take part

MS (type not specified) · 18 to 80

Show the full criteria

Inclusion criteria

* Meets migraine criteria based on International Classification of Headache Disorders (ICHD) 3 beta (based on questions in RedCap * 4 or more headache days per month

Exclusion criteria

* Patients who have had Cognitive Behavioral Therapy, Biofeedback or other Relaxation Therapy for Migraine in the past year * Cognitive deficit or other physical problem with the potential to interfere with behavioral therapy * Alcohol or other substance abuse as determined by self-report or prior documentation in the medical record * Opioid or barbiturate use 10+ days a month * Unable or unwilling to follow a treatment program that relies on written and audio recorded materials * Not having a smartphone

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

The goal of this research is to assess the utility of smartphone-based progressive muscle relaxation (PMR) for the treatment of headaches. While there are many commercially available electronic diary and mind-body intervention apps for headache, there is little data showing their efficacy. RELAXaHEAD app incorporates the electronic PMR that was successfully used in an earlier epilepsy study and beta tested with headache specialist and migraine patient input. It also is an electric headache diary. This 2-arm randomized controlled study will evaluate the feasibility and acceptability of RELAX for use with headache patients. One arm will be the RELAX group (the RELAXaHEAD app) and the other arm will be a monitored usual care (MUC) group (this group receives standard of care and uses the electronic daily symptom reporting diary). The goals are to assess the feasibility and adherence of the RELAX intervention in persons with headache (Aim 1) and to gather exploratory data on the effects of the RELAX intervention on headache related outcome measures (Aim 2).

Papers

Loading reviews and guidelines…

History

    1. Started

      Nov 2017

    2. Main results due

      May 2019

    3. Finished

      May 2019

    Assembled by software from public sources.